Phase 2a Study of AdV-tk With Standard Radiation Therapy for Malignant Glioma

This study is currently recruiting participants.

Study NCT00589875 Information provided by Advantagene, Inc.

First Received: December 27, 2007 Last Updated: October 27, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	May 2011 (Final data collection date for primary outcome measure)